Virtual Conference • July 22-23, 2020
Quality in Community-based Palliative Care Programs
Includes a Live Event on 07/22/2020 at 1:45 PM (EDT)
This session will explore quality measurement and improvement in palliative care. The focus will be on community-based palliative care, how it differs from hospice quality reporting.
- Describe the need for quality measurement in community-based palliative care
- Describe the different ways to use quality measurement to improve value
Arif Kamal, MBA,MD,MHS
Associate Professor of Medicine and Physician Quality Officer, Duke University Medical Center
Dr. Kamal is a medical oncologist, palliative medicine physician and health technology researcher, Associate Professor of Medicine at Duke University, and Physician Quality and Outcomes Officer at the Duke Cancer Institute. In these roles he studies the development and implementation of novel tools to engage seriously ill persons and their caregivers in their journey with illness, with the ultimate goal of improving quality of healthcare delivery.
Dr. Kamal holds several influential national leadership positions, including with the Physician Consortium for Performance Improvement (PCPI), The Joint Commission (TJC), National Quality Forum (NQF), American Society of Clinical Oncology (ASCO), American Academy of Hospice and Palliative Medicine (AAHPM). He has also won the Association of Community Cancer Centers (ACCC) Innovator Award and was selected as one the Top Influential Leaders Under 40 from AAHPM. He has published over 80 peer-reviewed articles in journals such as JAMA, Journal of Clinical Oncology, Annals of Internal Medicine, and Lancet Oncology. He holds grant funding from the Agency for Healthcare Research and Quality (AHRQ), CMS Innovations Center, and Cambia Health Foundation.
Dr. Kamal received his medical degree from the University of Missouri-Kansas City, completed Internal Medicine residency and Hospice and Palliative Medicine fellowship at the Mayo Clinic, and hematology/oncology fellowship at Duke University. He holds a Masters in Health Science in Clinical Research from Duke University and a Master in Business Administration from the University of Massachusetts – Amherst.